1. Glycopyrrolate during sevoflurane–remifentanil-based anaesthesia for cardiac catheterization of children with congenital heart disease 
K. Reyntjens, L. Foubert, D. De Wolf, G. Vanlerberghe, E. Mortier 
British Journal of Anaesthesia 
Volume 95, Issue 5, Pages (November 2005)
DOI: /bja/aei254
Copyright © 2005 British Journal of Anaesthesia Terms and Conditions

2. Fig 1
Heart rate (HR) during remifentanil infusion in the three groups: Group G0, placebo; Group G6, glycopyrrolate 6 µg kg−1; Group G12, glycopyrrolate 12 µg kg−1. T0 is time period before starting remifentanil infusion, T12.5–T45 relate to 12.5–45 min after starting the infusion. Data are mean (sd). *P<0.05 vs T0; †P<0.05 vs both Group G6 and Group G12.
British Journal of Anaesthesia  , DOI: ( /bja/aei254)
Copyright © 2005 British Journal of Anaesthesia Terms and Conditions

3. Fig 2
Changes in MAP during remifentanil infusion. Group G0, placebo; Group G6, glycopyrrolate 6 µg kg−1; Group G12, glycopyrrolate 12 µg kg−1. T0 is time period before starting remifentanil infusion, T12.5–T45 relate to 12.5–45 min after starting the infusion. Data are mean (sd) *P<0.05 vs T0; #P<0.05 vs T0; §P<0.05 vs T0, within each group.
British Journal of Anaesthesia  , DOI: ( /bja/aei254)
Copyright © 2005 British Journal of Anaesthesia Terms and Conditions